Search results for abx831236

Inclacumab, Abbexa, abx831236

Inclacumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SELP, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Inclacumab has been used in trials studying the treatment and prevention of Myocardial Infarction, Peripheral Arterial Disease (PAD), and Coronary Heart Disease, Graft Occlusion, Vascular.